A Practical Guide to Breast Cancer Screening (& How Hormone Therapy May Impact These Decisions)
A Practical Guide to Breast Cancer Screening
(and How Hormone Therapy May Impact These Decisions)
Date: Tuesday, October 21, 2025
Time: 8:00 AM EST / 5:00 AM PST
Format: Live Virtual Webinar
Access: Perry Academy Members (Core & Advanced)
Note: CME credit will be available once this session is live on Perry Academy.
Speakers
Dr. Robin Noble, MD — Gynecology
Dr. Eleni Nackos, MD — Medical Oncology
About the Session
Breast cancer screening continues to evolve — and so does the conversation around how hormone therapy may influence those decisions.
In this live webinar, Dr. Robin Noble and Dr. Eleni Nackos bring together gynecology and oncology expertise to provide a clear, practical approach to breast cancer screening in midlife women.
The session will focus on how to personalize screening protocols, interpret imaging findings with confidence, and navigate shared decision-making when menopausal hormone therapy is part of the discussion.
Learning Objectives
By the end of this session, participants will be able to:
Differentiate current breast cancer screening guidelines across major societies and align screening frequency and modality with patient age, risk profile, and preferences.
Apply validated risk assessment tools to identify high-risk individuals and determine appropriate use of supplemental imaging such as MRI or ultrasound.
Integrate knowledge of breast density classification and its diagnostic implications to optimize screening accuracy and follow-up strategies.
Formulate patient-centered screening plans that balance clinical benefit with potential harms, incorporating shared decision-making and cost considerations.
Evaluate abnormal imaging findings, coordinate biopsy procedures, and interpret results to guide next steps in management and multidisciplinary care.
Understand how hormone therapy may impact breast density and breast cancer screening decisions.
Recognize how breast cancer risk may influence decisions to initiate or continue menopausal hormone therapy (MHT).
Live access is limited to Perry Academy Members (Core & Advanced).
The CME-accredited version will be available on-demand once published on Perry Academy.